Urology · Germantown, TN
NPI
1124085634
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1325 Wolf Park Dr, Suite 102
Germantown, TN, 38138
Phone (901) 252-3400
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.0M
71,074 services
Medicare patients, 2024
1,398
Average age 75
Drug cost, 2024
$13.8M
3,973 prescriptions
Company payments, 2025
$71K
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul R Eber was code J1071 (injection, testosterone cypionate, 1 mg), 25,521 times for 34 patients. In total Paul R Eber billed 71,074 services in 152 codes, and Medicare paid $2.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-09-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 25,521 | 34 | $0.01 | $357 |
| J0897 Injection, denosumab, 1 mg | Office | 10,500 | 46 | $20.54 | $216K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 9,189 | 104 | $0.11 | $969 |
| J1050 Injection, medroxyprogesterone acetate, 1 mg | Office | 2,300 | 12 | $0.22 | $508 |
| 99214 Office E&M - Established | Office | 1,864 | 1,098 | $81.90 | $153K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,534 | 1,032 | $11.18 | $17K |
| 36415 Venipuncture Blood Collection | Office | 1,414 | 845 | $8.63 | $12K |
| 82570 Clinical Chemistry | Office | 1,360 | 928 | $5.02 | $6,828 |
| 81001 Clinical Chemistry | Office | 1,360 | 927 | $3.08 | $4,183 |
| 84153 Clinical Chemistry | Office | 1,274 | 768 | $17.96 | $23K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,083 | 199 | $43.70 | $47K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 608 | 175 | $34.25 | $21K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 588 | 121 | $43.26 | $25K |
| 87798 Infectious Agent Detection by DNA/RNA | Office | 569 | 82 | $34.39 | $20K |
| 84403 Clinical Chemistry | Office | 519 | 241 | $25.12 | $13K |
By year: 2022 $2.5M for 86,540 services; 2023 $1.2M for 88,293 services; 2024 $2.0M for 71,074 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,414 | 845 | $8.63 | $12K |
| 81001 Clinical Chemistry | 1,360 | 927 | $3.08 | $4,183 |
| 82570 Clinical Chemistry | 1,360 | 928 | $5.02 | $6,828 |
| 84153 Clinical Chemistry | 1,274 | 768 | $17.96 | $23K |
| 87798 Infectious Agent Detection by DNA/RNA | 569 | 82 | $34.39 | $20K |
| 84403 Clinical Chemistry | 519 | 241 | $25.12 | $13K |
| 81007 Clinical Chemistry | 113 | 105 | $29.38 | $3,320 |
| 82945 Clinical Chemistry | 113 | 105 | $3.85 | $435 |
| 82010 Clinical Chemistry | 113 | 105 | $8.01 | $905 |
| 84156 Clinical Chemistry | 113 | 105 | $3.60 | $407 |
Medicare prescription drug claims, 2024
In 2024, the drug Paul R Eber prescribed most often to Medicare patients was Orgovyx (Relugolix), with 727 prescriptions and refills. In total Paul R Eber wrote 3,973 Medicare prescriptions that cost $13.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Orgovyx Relugolix | 727 | 733 | 110 | $1.9M |
| Tamsulosin Hcl Generic | 662 | 1,778 | 224 | $13K |
| Erleada Apalutamide | 436 | 439 | 49 | $6.1M |
| Nubeqa Darolutamide | 203 | 203 | 26 | $2.7M |
| Dutasteride Generic | 162 | 462 | 56 | $5,446 |
| Xtandi Enzalutamide | 149 | 149 | 20 | $2.1M |
| Prednisone Generic | 149 | 165 | 18 | $1,123 |
| Finasteride Generic | 135 | 373 | 40 | $1,797 |
| Abiraterone Acetate Generic | 131 | 135 | 15 | $166K |
| Cephalexin Generic | 124 | 309 | 41 | $1,746 |
| Solifenacin Succinate Generic | 105 | 258 | 43 | $8,880 |
| Myrbetriq Mirabegron | 83 | 134 | 18 | $60K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 74 | 188 | 22 | $2,520 |
| Gemtesa Vibegron | 73 | 129 | 20 | $60K |
| Silodosin Generic | 70 | 135 | 21 | $4,055 |
Brand drugs: 1,737 claims; generic drugs: 2,236 claims; opioid claims: 50.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul R Eber $71K ($71K in general payments such as food, travel and fees) from 24 companies. The largest payer was Janssen Biotech, Inc. with $24K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 26 | $24K |
| Dendreon Pharmaceuticals LLC | 14 | $21K |
| Astellas Pharma US Inc 4503.T | 13 | $15K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $4,837 |
| Avyxa Pharma, LLC | 6 | $3,371 |
| Ferring Pharmaceuticals Inc. | 3 | $311 |
| Sumitomo Pharma America, Inc. 4506.T | 11 | $279 |
| Urogen Pharma, Inc. URGN | 8 | $270 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $171 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $150 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.